IJsfontein B.V., Netherlands
IJsfontein B.V., Netherlands
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage | Disease Attributes, Nutritional and Metabolic Diseases, Parkinson disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Prodromal Stage, Prodromal Symptoms, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, disease susceptibility, inherited disease susceptibility, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, synucleinopathy | Recruiting | Not applicable | 2026-08-27 | NCT06993142 | |
| Slow-SPEED-NL: Slowing Parkinson's Early Through Exercise Dosage-Netherlands | Nutritional and Metabolic Diseases, Parasomnias, Parkinson disease, Pathological Conditions, Signs and Symptoms, Prodromal Stage, Prodromal Symptoms, REM Sleep Parasomnias, REM sleep behavior disorder, Signs and Symptoms, basal ganglia disorder, brain disorder, central nervous system disorder, metabolic disease, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, proteostasis deficiencies, psychiatric disorder, sleep-wake disorder, synucleinopathy | Recruiting | Not applicable | 2026-08-27 | NCT06193252 | |
| Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity | Cognition Disorders, Cognitive Dysfunction, Nutritional and Metabolic Diseases, Parkinson disease, Pathological Conditions, Signs and Symptoms, Prodromal Stage, Prodromal Symptoms, Signs and Symptoms, autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, dementia, metabolic disease, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, proteostasis deficiencies, psychiatric disorder, synucleinopathy | Recruiting | Not applicable | 2026-01-16 | NCT07324330 |